Tenet Healthcare earnings loom as investors eye 2027 outlook

Tenet Healthcare (THC) reports Q3 earnings with analysts expecting $4.67 EPS on $5.49B revenue, down from Q2. Wall Street is bullish, with a mean price target of $286.41. Investors focus on hospital segment growth, ambulatory surgery center M&A, and 2027 outlook amid a $290M EBITDA headwind.

Original reporting
Published Oct 28, 2026, 3:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 3:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$THC
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

Med
01

Why it matters

The new Q3 guidance and expanded buyback program suggest continued momentum, but 2027 headwinds could temper optimism.

02

Market read

Earnings preview with fresh guidance provides actionable insight for traders ahead of the report.

03

What to watch

Potential impact of the $290M EBITDA headwind from Conifer contract termination.

Relevance 8/10Novelty 8/10Timing: pre‑market Thursday

Background

Tenet Healthcare is a major U.S. hospital operator with recent strong Q2 performance.

Market effects

Hospital operator earnings may set tone for healthcare sector expectations.

U.S. healthcare stocks could see modest gains.

Limited to U.S. markets.

Counterpoint

If guidance falls short of market expectations, the stock could face a sell‑off despite buyback news.

Key entities

  • Tenet Healthcare Corporation

    U.S. hospital operator reporting earnings.

  • Guggenheim

    Raised price target on Tenet.

Related articles

$HCAMed

Hospital Stocks Soared as Democrats Took Congress

HCA Healthcare (HCA) rose 10.34% to $510.70 on November 4, 2026, following Democratic gains in the U.S. election. Investors anticipate potential policy changes favoring hospitals and Medicaid insurers. Universal Health Services (UHS) and Tenet Healthcare (THC) also saw significant gains. HCA's stock is now valued at $106.68 billion, but analysts warn of potential downside risks if policy changes do not materialize.

$THCHighAI 8/10

Mizuho raises Tenet Healthcare stock price target on strong results

Mizuho increased its price target for Tenet Healthcare (NYSE:THC) to $305 from $290, citing strong quarterly results and raised 2026 EBITDA estimates. The stock trades near its 52-week high after a 49% six-month surge. Tenet reported Q3 2026 EPS of $6.64, beating estimates, and raised its full-year EBITDA outlook. Guggenheim maintained a Buy rating with a slightly lowered target of $306.

$THCMed

Tenet Healthcare Q3 Earnings Call Highlights

Tenet Healthcare (THC) reported Q3 earnings, with hospital segment showing 3.2% growth in admissions and 11% adjusted EBITDA increase. Revenue per admission rose 0.2% YoY. Exchange admissions and revenues declined 18%. Conifer transition activities contributed $147M, with $450M expected in 2026. Tenet generated $1.1B in adjusted free cash flow and repurchased 970K shares.